Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Surufatinib”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Very early researchStudy completedNCT03627520
What this trial is testing

A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion of [14C]Sulfatinib

Who this might be right for
Healthy
Hutchison Medipharma Limited 6
Testing effectiveness (Phase 2)UnknownNCT05030246
What this trial is testing

Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal Cancer

Who this might be right for
Refractory Metastatic Digestive System CarcinomaPrimary Peritoneal Cancer
Peking University 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05882630
What this trial is testing

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)UnknownNCT05106777
What this trial is testing

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 47
Early research (Phase 1)Study completedNCT02267967
What this trial is testing

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Hutchison Medipharma Limited 81
Testing effectiveness (Phase 2)Study completedNCT05481463
What this trial is testing

Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 22
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Testing effectiveness (Phase 2)UnknownNCT05627427
What this trial is testing

Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy

Who this might be right for
Neuroendocrine Tumor Grade 3Neuroendocrine CarcinomaPancreatic Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05988372
What this trial is testing

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

Who this might be right for
Locally Advanced Pancreatic Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT05171439
What this trial is testing

Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05722977
What this trial is testing

Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients

Who this might be right for
Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
Peking Union Medical College Hospital 45
Not applicableUnknownNCT05013515
What this trial is testing

Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas

Who this might be right for
Salivary Gland Carcinomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 20
Testing effectiveness (Phase 2)Looking for participantsNCT04922658
What this trial is testing

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06447636
What this trial is testing

Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerGastro Esophageal Junction Cancer
Fudan University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05926492
What this trial is testing

A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Who this might be right for
Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 160
Not applicableUnknownNCT05064852
What this trial is testing

A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Qilu Hospital of Shandong University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Testing effectiveness (Phase 2)UnknownNCT06134193
What this trial is testing

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Large-scale testing (Phase 3)UnknownNCT03873532
What this trial is testing

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Who this might be right for
Biliary Tract Cancer
Hutchison Medipharma Limited 298
Early research (Phase 1)Study completedNCT04372407
What this trial is testing

Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects

Who this might be right for
Healthy
Hutchison Medipharma Limited 13
Load More Results